IN2012DN00770A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN00770A IN2012DN00770A IN770DEN2012A IN2012DN00770A IN 2012DN00770 A IN2012DN00770 A IN 2012DN00770A IN 770DEN2012 A IN770DEN2012 A IN 770DEN2012A IN 2012DN00770 A IN2012DN00770 A IN 2012DN00770A
- Authority
- IN
- India
- Prior art keywords
- hydrogen atom
- group
- substituent
- aromatic heterocyclic
- membered aromatic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
A compound represented by the general formula (I) of the present invention, which has an EP1 receptor antagonism: [Chem.] [wherein A represents a benzene ring or the like; Y represents a C1-6 alkylene group or the like; RN represents a hydrogen atom or a C1-6 alkyl group; R1 represents a hydrogen atom, a C1-6 alkyl group or the like; R2 represents a phenyl group which may have a substituent, a 5-membered aromatic heterocyclic group which may have a substituent, a 6-membered aromatic heterocyclic group which may have a substituent or the like;R3 represents a halogen atom, a C1-6 alkoxy group or the like; R4 represents a hydrogen atom or the like; and R5 represents a hydrogen atom or the like] or a pharmaceutically acceptable salt thereof is provided. Furthermore, the compound (I) of the present invention can be used as an agent for treating or preventing LUTS, in particular, various symptoms of OABs.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009173852 | 2009-07-27 | ||
JP2009252846 | 2009-11-04 | ||
PCT/JP2010/062532 WO2011013623A1 (en) | 2009-07-27 | 2010-07-26 | Indole derivative and pharmacologically acceptable salt thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN00770A true IN2012DN00770A (en) | 2015-06-26 |
Family
ID=43529279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN770DEN2012 IN2012DN00770A (en) | 2009-07-27 | 2010-07-26 |
Country Status (17)
Country | Link |
---|---|
US (1) | US20120122931A1 (en) |
EP (1) | EP2474530B1 (en) |
JP (1) | JPWO2011013623A1 (en) |
KR (1) | KR20120039038A (en) |
CN (2) | CN104151292A (en) |
AU (1) | AU2010279155A1 (en) |
BR (1) | BR112012001953A2 (en) |
CA (1) | CA2768814A1 (en) |
IL (1) | IL217705A0 (en) |
IN (1) | IN2012DN00770A (en) |
MX (1) | MX2012001275A (en) |
NZ (1) | NZ597810A (en) |
RU (1) | RU2012106822A (en) |
SG (1) | SG178089A1 (en) |
TW (1) | TW201107309A (en) |
WO (1) | WO2011013623A1 (en) |
ZA (1) | ZA201200585B (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2012102254A1 (en) | 2011-01-25 | 2014-06-30 | キッセイ薬品工業株式会社 | Indole derivatives or pharmacologically acceptable salts thereof |
TW201309670A (en) * | 2011-01-25 | 2013-03-01 | Kissei Pharmaceutical | Indole derivative and pharmacologically acceptable salt of same |
WO2014017342A1 (en) * | 2012-07-24 | 2014-01-30 | キッセイ薬品工業株式会社 | Indole derivative or pharmacologically acceptable salt thereof |
JP2015178458A (en) * | 2012-07-25 | 2015-10-08 | 杏林製薬株式会社 | Benzene ring-condensed nitrogen-containing five-membered heterocyclic compound and pharmacologically permissible salt of the same |
JP2015178457A (en) * | 2012-07-25 | 2015-10-08 | 杏林製薬株式会社 | Pyrazolopyridine derivative and pharmacologically permissible salt of the same |
WO2014087208A2 (en) * | 2012-12-06 | 2014-06-12 | Enaltec Labs Pvt. Ltd. | A process of preparing alcaftadine |
JP6090666B2 (en) * | 2013-05-20 | 2017-03-08 | 国立大学法人富山大学 | Indole derivatives and hypoglycemic agents. |
CN107001267A (en) * | 2014-08-08 | 2017-08-01 | 马合伙人株式会社 | Condensed heterocyclic compouds |
CN107325067B (en) * | 2017-05-03 | 2020-05-12 | 广州中医药大学 | Mulberry octyl element M derivative of phosphodiesterase 4 inhibitor and application thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4510158A (en) * | 1984-03-05 | 1985-04-09 | Sterling Drug Inc. | 2-Phenylindole derivatives, their use as complement inhibitors |
WO1998051667A1 (en) * | 1997-05-16 | 1998-11-19 | Chugai Seiyaku Kabushiki Kaisha | Indole derivatives and mono- and diazaindole derivatives |
GB9718833D0 (en) * | 1997-09-04 | 1997-11-12 | Merck Sharp & Dohme | Therapeutic agents |
ES2286230T3 (en) * | 2001-03-12 | 2007-12-01 | Ono Pharmaceutical Co., Ltd. | N-PHENYLARSULFONAMIDE COMPOUND, A MEDICINAL PRODUCT CONTAINING THE COMPOUND AS AN INTERMEDIATE ACTIVE PRINCIPLE FOR THE COMPOUND AND PROCEDURE TO PRODUCE THEM. |
US20050215589A1 (en) * | 2003-09-03 | 2005-09-29 | Roger Crossley | Inhibitors of 5-HT2A receptor |
GB0428263D0 (en) * | 2004-12-23 | 2005-01-26 | Glaxo Group Ltd | Compounds |
RU2452479C2 (en) * | 2007-02-16 | 2012-06-10 | Оно Фармасьютикал Ко., Лтд. | Therapeutic agent in disturbed urination |
JP2008214224A (en) | 2007-03-01 | 2008-09-18 | Ono Pharmaceut Co Ltd | Thiazolylsulfonylamide compound |
AR072297A1 (en) * | 2008-06-27 | 2010-08-18 | Novartis Ag | DERIVATIVES OF INDOL-2-IL-PIRIDIN-3-ILO, PHARMACEUTICAL COMPOSITION THAT INCLUDES THEM AND ITS USE IN MEDICINES FOR THE TREATMENT OF DISEASES MEDIATED BY THE SYNTHESIS ALDOSTERONE. |
-
2010
- 2010-07-23 TW TW099124286A patent/TW201107309A/en unknown
- 2010-07-26 AU AU2010279155A patent/AU2010279155A1/en not_active Abandoned
- 2010-07-26 EP EP10804369.6A patent/EP2474530B1/en active Active
- 2010-07-26 NZ NZ597810A patent/NZ597810A/en not_active IP Right Cessation
- 2010-07-26 MX MX2012001275A patent/MX2012001275A/en active IP Right Grant
- 2010-07-26 IN IN770DEN2012 patent/IN2012DN00770A/en unknown
- 2010-07-26 KR KR1020127004834A patent/KR20120039038A/en not_active Application Discontinuation
- 2010-07-26 BR BR112012001953A patent/BR112012001953A2/en not_active IP Right Cessation
- 2010-07-26 CN CN201410329462.8A patent/CN104151292A/en active Pending
- 2010-07-26 RU RU2012106822/04A patent/RU2012106822A/en not_active Application Discontinuation
- 2010-07-26 CA CA2768814A patent/CA2768814A1/en not_active Abandoned
- 2010-07-26 CN CN2010800417819A patent/CN102498097A/en active Pending
- 2010-07-26 JP JP2011524768A patent/JPWO2011013623A1/en not_active Ceased
- 2010-07-26 US US13/387,291 patent/US20120122931A1/en not_active Abandoned
- 2010-07-26 WO PCT/JP2010/062532 patent/WO2011013623A1/en active Application Filing
- 2010-07-26 SG SG2012004867A patent/SG178089A1/en unknown
-
2012
- 2012-01-24 ZA ZA2012/00585A patent/ZA201200585B/en unknown
- 2012-01-24 IL IL217705A patent/IL217705A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20120122931A1 (en) | 2012-05-17 |
MX2012001275A (en) | 2012-11-23 |
ZA201200585B (en) | 2013-05-29 |
TW201107309A (en) | 2011-03-01 |
CA2768814A1 (en) | 2011-02-03 |
EP2474530A1 (en) | 2012-07-11 |
WO2011013623A1 (en) | 2011-02-03 |
NZ597810A (en) | 2013-03-28 |
AU2010279155A1 (en) | 2012-02-23 |
CN102498097A (en) | 2012-06-13 |
EP2474530B1 (en) | 2014-09-03 |
KR20120039038A (en) | 2012-04-24 |
IL217705A0 (en) | 2012-03-29 |
JPWO2011013623A1 (en) | 2013-01-07 |
EP2474530A4 (en) | 2013-01-02 |
SG178089A1 (en) | 2012-03-29 |
BR112012001953A2 (en) | 2016-11-08 |
RU2012106822A (en) | 2013-09-10 |
CN104151292A (en) | 2014-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN00770A (en) | ||
MX2011008305A (en) | Pyridazinone compounds. | |
MX2009004920A (en) | Novel aminopyrimidine derivatives as plk1 inhibitors. | |
MD20110063A2 (en) | Herbicidal compositions containing benzoylpyrazole compounds | |
WO2009054332A1 (en) | Pyridone-substituted-dihydropyrazolopyrimidinone derivative | |
IN2012DN00768A (en) | ||
EP1867331A4 (en) | Triazole derivative and the use thereof | |
MY139887A (en) | Tetrahydronaphthyridine derivatives and a process for preparing the same. | |
MY160443A (en) | Nitrogen-containing heterocyclic compound and agricultural fungicide | |
MY148703A (en) | Polycyclic cinnamide derivatives | |
MX361020B (en) | Process for preparing heterocyclic compounds including trans-7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carbo xamide and salts thereof. | |
MY150507A (en) | Polycyclic compound | |
MX2007000035A (en) | Cetp inhibitors. | |
MX2009012283A (en) | Nitrogen-containing heterocyclic derivative having 11 î²-hydroxysteroid dehydrogenase type i inhibitory activity. | |
MY152972A (en) | Azabicyclo compound and salt thereof | |
TW200833324A (en) | Sulfonamide derivatives | |
TN2011000422A1 (en) | Benzofuran derivatives | |
WO2009054439A1 (en) | Pai-1 production inhibitor | |
WO2009038064A1 (en) | Heterocyclic derivative having inhibitory activity on type-i 11β-hydroxysteroid dehydrogenase | |
MX2012003469A (en) | Imidazopyridine or imidazopyrimidine derivatives as phosphodiesterase 10a inhibitors. | |
MX2012015098A (en) | Fused heterocyclic compounds as phosphodiesterases (pdes) inhibitors. | |
MX2010008637A (en) | Novel phenylpyrrole derivative. | |
HK1138262A1 (en) | Novel phosphodiesterase inhibitors | |
WO2008126901A1 (en) | Nitrogen-containing heterocyclic compound and pharmaceutical composition containing the same | |
GEP20125637B (en) | Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them |